|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen PC, Kuo C, Pan CC and Chou MY: Risk
of oral cancer associated with human papillomavirus infection,
betel quid chewing, and cigarette smoking in Taiwan - an integrated
molecular and epidemiological study of 58 cases. J Oral Pathol Med.
31:317–322. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Franceschi S, Talamini R, Barra S, Barón
AE, Negri E, Bidoli E, Serraino D and La Vecchia C: Smoking and
drinking in relation to cancers of the oral cavity, pharynx,
larynx, and esophagus in northern Italy. Cancer Res. 50:6502–6507.
1990.PubMed/NCBI
|
|
4
|
Cancela MC, Ramadas K, Fayette JM, Thomas
G, Muwonge R, Chapuis F, Thara S, Sankaranarayanan R and Sauvaget
C: Alcohol intake and oral cavity cancer risk among men in a
prospective study in Kerala, India. Community Dent Oral Epidemiol.
37:342–349. 2009. View Article : Google Scholar
|
|
5
|
Kimple RJ, Smith MA, Blitzer GC, Torres
AD, Martin JA, Yang RZ, Peet CR, Lorenz LD, Nickel KP, Klingelhutz
AJ, et al: Enhanced radiation sensitivity in HPV-positive head and
neck cancer. Cancer Res. 73:4791–4800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chinn SB and Myers JN: Oral cavity
carcinoma: Current management, controversies, and future
directions. J Clin Oncol. 33:3269–3276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
da Silva SD, Hier M, Mlynarek A, Kowalski
LP and Alaoui-Jamali MA: Recurrent oral cancer: Current and
emerging therapeutic approaches. Front Pharmacol. 3:1492012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Poh CF, Durham JS, Brasher PM, Anderson
DW, Berean KW, MacAulay CE, Lee JJ and Rosin MP: Canadian
Optically-guided approach for Oral Lesions Surgical (COOLS) trial:
Study protocol for a randomized controlled trial. BMC Cancer.
11:4622011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carvalho AL, Kowalski LP, Agra IM, Pontes
E, Campos OD and Pellizzon AC: Treatment results on advanced neck
metastasis (N3) from head and neck squamous carcinoma. Otolaryngol
Head Neck Surg. 132:862–868. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Furness S, Glenny AM, Worthington HV,
Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK and Conway
DI: Interventions for the treatment of oral cavity and
oropharyngeal cancer: Chemotherapy. Cochrane Database Syst Rev.
(4): CD0063862011.PubMed/NCBI
|
|
11
|
National Cancer Institute. Surveillance,
Epidemiology, and End Results (SEER) Program. National Cancer
Institute Surveillance Research Program. based on November 2006
submission of SEER series 9 (1996–2003). 2006
|
|
12
|
Chinn SB, Spector ME, Bellile EL, McHugh
JB, Gernon TJ, Bradford CR, Wolf GT, Eisbruch A and Chepeha DB:
Impact of perineural invasion in the pathologically N0 neck in oral
cavity squamous cell carcinoma. Otolaryngol Head Neck Surg.
149:893–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Daigo Y and Nakamura Y: From cancer
genomics to thoracic oncology: Discovery of new biomarkers and
therapeutic targets for lung and esophageal carcinoma. Gen Thorac
Cardiovasc Surg. 56:43–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Daigo Y, Takano A, Teramoto K, Chung S and
Nakamura Y: A systematic approach to the development of novel
therapeutics for lung cancer using genomic analyses. Clin Pharmacol
Ther. 94:218–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishikawa N, Daigo Y, Takano A, Taniwaki M,
Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, et
al: Increases of amphiregulin and transforming growth factor-alpha
in serum as predictors of poor response to gefitinib among patients
with advanced non-small cell lung cancers. Cancer Res.
65:9176–9184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishikawa N, Daigo Y, Yasui W, Inai K,
Nishimura H, Tsuchiya E, Kohno N and Nakamura Y: ADAM8 as a novel
serological and histochemical marker for lung cancer. Clin Cancer
Res. 10:8363–8370. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kakiuchi S, Daigo Y, Ishikawa N, Furukawa
C, Tsunoda T, Yano S, Nakagawa K, Tsuruo T, Kohno N, Fukuoka M, et
al: Prediction of sensitivity of advanced non-small cell lung
cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet. 13:3029–3043.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kato T, Daigo Y, Hayama S, Ishikawa N,
Yamabuki T, Ito T, Miyamoto M, Kondo S and Nakamura Y: A novel
human tRNA-dihydrouridine synthase involved in pulmonary
carcinogenesis. Cancer Res. 65:5638–5646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kikuchi T, Daigo Y, Katagiri T, Tsunoda T,
Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi
K, et al: Expression profiles of non-small cell lung cancers on
cDNA microarrays: Identification of genes for prediction of
lymph-node metastasis and sensitivity to anti-cancer drugs.
Oncogene. 22:2192–2205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki C, Daigo Y, Ishikawa N, Kato T,
Hayama S, Ito T, Tsuchiya E and Nakamura Y: ANLN plays a critical
role in human lung carcinogenesis through the activation of RHOA
and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Cancer Res. 65:11314–11325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kakiuchi S, Daigo Y, Tsunoda T, Yano S,
Sone S and Nakamura Y: Genome-wide analysis of organ-preferential
metastasis of human small cell lung cancer in mice. Mol Cancer Res.
1:485–499. 2003.PubMed/NCBI
|
|
22
|
Taniwaki M, Daigo Y, Ishikawa N, Takano A,
Tsunoda T, Yasui W, Inai K, Kohno N and Nakamura Y: Gene expression
profiles of small-cell lung cancers: Molecular signatures of lung
cancer. Int J Oncol. 29:567–575. 2006.PubMed/NCBI
|
|
23
|
Oshita H, Nishino R, Takano A, Fujitomo T,
Aragaki M, Kato T, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y, et
al: RASEF is a novel diagnostic biomarker and a therapeutic target
for lung cancer. Mol Cancer Res. 11:937–951. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayama S, Daigo Y, Yamabuki T, Hirata D,
Kato T, Miyamoto M, Ito T, Tsuchiya E, Kondo S and Nakamura Y:
Phosphorylation and activation of cell division cycle associated 8
by aurora kinase B plays a significant role in human lung
carcinogenesis. Cancer Res. 67:4113–4122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishikawa N, Daigo Y, Takano A, Taniwaki M,
Kato T, Tanaka S, Yasui W, Takeshima Y, Inai K, Nishimura H, et al:
Characterization of SEZ6L2 cell-surface protein as a novel
prognostic marker for lung cancer. Cancer Sci. 97:737–745. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kato T, Sato N, Hayama S, Yamabuki T, Ito
T, Miyamoto M, Kondo S, Nakamura Y and Daigo Y: Activation of
Holliday junction recognizing protein involved in the chromosomal
stability and immortality of cancer cells. Cancer Res.
67:8544–8553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suzuki C, Takahashi K, Hayama S, Ishikawa
N, Kato T, Ito T, Tsuchiya E, Nakamura Y and Daigo Y:
Identification of Myc-associated protein with JmjC domain as a
novel therapeutic target oncogene for lung cancer. Mol Cancer Ther.
6:542–551. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takahashi K, Furukawa C, Takano A,
Ishikawa N, Kato T, Hayama S, Suzuki C, Yasui W, Inai K, Sone S, et
al: The neuromedin U-growth hormone secretagogue receptor
1b/neurotensin receptor 1 oncogenic signaling pathway as a
therapeutic target for lung cancer. Cancer Res. 66:9408–9419. 2006.
View Article : Google Scholar
|
|
29
|
Taniwaki M, Takano A, Ishikawa N, Yasui W,
Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y and Daigo Y:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13:6624–6631. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamabuki T, Takano A, Hayama S, Ishikawa
N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, et al:
Dikkopf-1 as a novel serologic and prognostic biomarker for lung
and esophageal carcinomas. Cancer Res. 67:2517–2525. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujitomo T, Daigo Y, Matsuda K, Ueda K and
Nakamura Y: Identification of a nuclear protein, LRRC42, involved
in lung carcinogenesis. Int J Oncol. 45:147–156. 2014.PubMed/NCBI
|
|
32
|
Nguyen MH, Koinuma J, Ueda K, Ito T,
Tsuchiya E, Nakamura Y and Daigo Y: Phosphorylation and activation
of cell division cycle associated 5 by mitogen-activated protein
kinase play a crucial role in human lung carcinogenesis. Cancer
Res. 70:5337–5347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hayama S, Daigo Y, Kato T, Ishikawa N,
Yamabuki T, Miyamoto M, Ito T, Tsuchiya E, Kondo S and Nakamura Y:
Activation of CDCA1-KNTC2, members of centromere protein complex,
involved in pulmonary carcinogenesis. Cancer Res. 66:10339–10348.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tomita Y, Yuno A, Tsukamoto H, Senju S,
Yoshimura S, Osawa R, Kuroda Y, Hirayama M, Irie A, Hamada A, et
al: Identification of CDCA1-derived long peptides bearing both
CD4+ and CD8+ T-cell epitopes: CDCA1-specific
CD4+ T-cell immunity in cancer patients. Int J Cancer.
134:352–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kobayashi Y, Takano A, Miyagi Y, Tsuchiya
E, Sonoda H, Shimizu T, Okabe H, Tani T, Fujiyama Y and Daigo Y:
Cell division cycle-associated protein 1 overexpression is
essential for the malignant potential of colorectal cancers. Int J
Oncol. 44:69–77. 2014.
|
|
36
|
Harao M, Hirata S, Irie A, Senju S,
Nakatsura T, Komori H, Ikuta Y, Yokomine K, Imai K, Inoue M, et al:
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated
cancer testis antigen, cell division cycle associated 1, can induce
tumor-reactive CTL. Int J Cancer. 123:2616–2625. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ciferri C, De Luca J, Monzani S, Ferrari
KJ, Ristic D, Wyman C, Stark H, Kilmartin J, Salmon ED and
Musacchio A: Architecture of the human ndc80-hec1 complex, a
critical constituent of the outer kinetochore. J Biol Chem.
280:29088–29095. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kaneko N, Miura K, Gu Z, Karasawa H,
Ohnuma S, Sasaki H, Tsukamoto N, Yokoyama S, Yamamura A, Nagase H,
et al: siRNA-mediated knockdown against CDCA1 and KNTC2, both
frequently overexpressed in colorectal and gastric cancers,
suppresses cell proliferation and induces apoptosis. Biochem
Biophys Res Commun. 390:1235–1240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Duin M, Broyl A, de Knegt Y,
Goldschmidt H, Richardson PG, Hop WC, van der Holt B,
Joseph-Pietras D, Mulligan G, Neuwirth R, et al: Cancer testis
antigens in newly diagnosed and relapse multiple myeloma:
Prognostic markers and potential targets for immunotherapy.
Haematologica. 96:1662–1669. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wan X, O‘Quinn RP, Pierce HL, Joglekar AP,
Gall WE, DeLuca JG, Carroll CW, Liu ST, Yen TJ, McEwen BF, et al:
Protein architecture of the human kinetochore microtubule
attachment site. Cell. 137:672–684. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sundin LJ, Guimaraes GJ and Deluca JG: The
NDC80 complex proteins Nuf2 and Hec1 make distinct contributions to
kinetochore-microtubule attachment in mitosis. Mol Biol Cell.
22:759–768. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
DeLuca JG, Howell BJ, Canman JC, Hickey
JM, Fang G and Salmon ED: Nuf2 and Hec1 are required for retention
of the checkpoint proteins Mad1 and Mad2 to kinetochores. Curr
Biol. 13:2103–2109. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
DeLuca JG, Moree B, Hickey JM, Kilmartin
JV and Salmon ED: hNuf2 inhibition blocks stable
kinetochore-microtubule attachment and induces mitotic cell death
in HeLa cells. J Cell Biol. 159:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu D, Ding X, Du J, Cai X, Huang Y, Ward
T, Shaw A, Yang Y, Hu R, Jin C, et al: Human NUF2 interacts with
centromere-associated protein E and is essential for a stable
spindle microtubule-kinetochore attachment. J Biol Chem.
282:21415–21424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhai Y, Kronebusch PJ and Borisy GG:
Kinetochore microtubule dynamics and the metaphase-anaphase
transition. J Cell Biol. 131:721–734. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yoshitake Y, Fukuma D, Yuno A, Hirayama M,
Nakayama H, Tanaka T, Nagata M, Takamune Y, Kawahara K, Nakagawa Y,
et al: Phase II clinical trial of multiple peptide vaccination for
advanced head and neck cancer patients revealed induction of immune
responses and improved OS. Clin Cancer Res. 21:312–321. 2015.
View Article : Google Scholar
|
